Status:
COMPLETED
Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041)
Lead Sponsor:
Organon and Co
Conditions:
Recurrent Low Back Pain
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
Study the effect of etoricoxib 60 mg and 90 mg compared to placebo to treat chronic low back pain.
Eligibility Criteria
Inclusion
- Low back pain for previous 3 months and majority of days in last month
- Regular use of acetaminophen or NSAID to treat low back pain in past month
- Judged to be in otherwise good health
Exclusion
- Low back pain that is due to secondary causes
- Radicular/myelopathic pain
- Surgery for low back pain within the past 6 months
- Active lawsuit or claim pertaining to their low back pain
- Disease that may confound the results of the study or pose risk to the patients
- Corticosteroid use in past month
- Previous participation in MK0663 study
Key Trial Info
Start Date :
April 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2000
Estimated Enrollment :
325 Patients enrolled
Trial Details
Trial ID
NCT00393354
Start Date
April 1 2000
End Date
November 1 2000
Last Update
February 18 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.